His laboratory
implicated endocannabinoids in axon guidance and identified the molecular substrates of Δ9 - tetrahydrocannabinol action in developing neurons.
It would also
implicate the endocannabinoid system as a potential therapeutic target to facilitate regeneration of neural connections destroyed by glaucoma.